Dexco SA (BSP:DXCO3)
R$ 7.49 -0.05 (-0.66%) Market Cap: 6.05 Bil Enterprise Value: 11.51 Bil PE Ratio: 0 PB Ratio: 0.95 GF Score: 85/100

Q4 2023 Dexco SA Earnings Call Transcript

Mar 07, 2024 / 01:00PM GMT
Release Date Price: R$7.68 (-4.12%)
Operator

Good morning, ladies and gentlemen, and welcome to Dexco's conference call where we will discuss our earnings for the fourth quarter of 2023.

This conference call is being recorded and this recording may be seen on the company's website, ri.dex.co. This presentation is also available for download. This call is also being recorded and English. Click on the globe icon on the lower bar of your screen and select English. And then select mute original audio. (Operator Instructions)

I would also like to say that prospective statements are based on the company's assumptions based on currently available information. They may involve risks and uncertainties as they refer to future events. And this depends on the circumstances that may or may not come to pass. Investors and analysts should understand that events related to macroeconomic factors and other might make these results may differ materially from those expressed in these forward-looking statements.

We have with us in the company, the executive directors and the Investor Relations team. I will now pass it over to Francisco Somera

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot